Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience.

Therapeutic hypothermia and targeted temperature management for traumatic brain injury: Experimental and clinical experience.
复制标题

DOI:
10.4103/bc.bc_28_17
复制
发表时间:
2017-10
期刊:
影响因子:
1.9
通讯作者:
Bramlett HM
Bramlett HM
中科院分区:
医学4区
文献类型:
--
作者:
Dietrich WD;Bramlett HM

文献摘要

被引文献

相似文献

创伤性脑损伤(TBI)是一个世界性的医学问题,目前,很少有治疗干预措施可以保护大脑并改善患者的功能结果。在过去的几十年里,实验研究调查了 TBI 的病理生理学,并测试了针对特定继发性损伤机制的各种药物治疗干预措施。尽管许多临床前治疗研究令人鼓舞,但仍缺乏成功转化为临床的研究,并且没有任何治疗方法在 3 期多中心试验中显示出益处。过去几十年来,低温治疗和有针对性的温度管理方案已证明可以成功减少继发性损伤机制,并且在某些选择性病例中,可以改善特定 TBI 患者群体的预后。然而,多中心随机试验尚未证明低温治疗能够显着改善神经系统结果。尽管无法将低温治疗转化为更大的临床人群的确切原因尚不清楚,但这种失败可能反映出这种潜在强大的治疗方法在可能可治疗的严重创伤患者中的使用效果不佳。众所周知,包括患者招募、临床治疗变量和冷却方法在内的多种因素对于产生有益效果都很重要。需要结合这些因素进行高质量的多中心随机对照试验,以最大限度地发挥这种实验疗法的益处。因此,本文总结了对于增强 TBI 低温治疗有益效果的几个重要因素。讨论了目前低温 TBI 临床试验在临床方案设计、患者部分和其他考虑因素方面的失败,并强调了未来的方向。
Traumatic brain injury (TBI) is a worldwide medical problem, and currently, there are few therapeutic interventions that can protect the brain and improve functional outcomes in patients. Over the last several decades, experimental studies have investigated the pathophysiology of TBI and tested various pharmacological treatment interventions targeting specific mechanisms of secondary damage. Although many preclinical treatment studies have been encouraging, there remains a lack of successful translation to the clinic and no therapeutic treatments have shown benefit in phase 3 multicenter trials. Therapeutic hypothermia and targeted temperature management protocols over the last several decades have demonstrated successful reduction of secondary injury mechanisms and, in some selective cases, improved outcomes in specific TBI patient populations. However, the benefits of therapeutic hypothermia have not been demonstrated in multicenter randomized trials to significantly improve neurological outcomes. Although the exact reasons underlying the inability to translate therapeutic hypothermia into a larger clinical population are unknown, this failure may reflect the suboptimal use of this potentially powerful therapeutic in potentially treatable severe trauma patients. It is known that multiple factors including patient recruitment, clinical treatment variables, and cooling methodologies are all important in yielding beneficial effects. High-quality multicenter randomized controlled trials that incorporate these factors are required to maximize the benefits of this experimental therapy. This article therefore summarizes several factors that are important in enhancing the beneficial effects of therapeutic hypothermia in TBI. The current failures of hypothermic TBI clinical trials in terms of clinical protocol design, patient section, and other considerations are discussed and future directions are emphasized.